Comparative Effects of Moderate Intensity Circuit Training and Moderate-Intensity Continuous Trai… (NCT07331623) | Clinical Trial Compass
CompletedNot Applicable
Comparative Effects of Moderate Intensity Circuit Training and Moderate-Intensity Continuous Training in Soccer Players
Pakistan56 participantsStarted 2025-03-21
Plain-language summary
This study will compare the effects of Moderate-Intensity Circuit Training (MICT) and Moderate-Intensity Continuous Training (MICT) on Heart rate recovery, VO₂ max, power, and agility in 40 male soccer players aged 18-25. Participants will be randomly assigned to either group, with two 45-minute sessions per week over 8 weeks. Pre- and post-intervention assessments will include heart rate recovery, VO₂ max, 5 Jump Test, and T-Test for agility. Statistical analyses will compare within- and between-group changes using paired t-tests and ANOVA. The goal is to determine which training method is more effective for enhancing athletic performance.
Who can participate
Age range
18 Years – 35 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male soccer players aged 18-35 years.
* Players with at least two years of competitive soccer experience and are in practice season.
* Players with a body mass index (BMI) within the range of 18.5 to 30 kg/m².
* Availability to attend all training sessions and assessments
Exclusion Criteria:
* Participants with medical conditions that contraindicate exercise.
* Athletes currently involved in other Moderate-Intensity continuous training programs.
* Presence of cardiovascular, neuromuscular, orthopedic, or neurologic conditions.
* Individuals who have undergone any surgery in the past six months.
* Those who do not provide written informed consent.
* Players taking any nutritional supplements, drugs, nicotine and alcohol.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.